Imaging for suspected pulmonary embolism in pregnancy—what about the fetal dose? A comprehensive review of the literature

Por Niemann, Tilo, Nicolas, Guillaume, Roser, Hans W., Müller-Brand, Jan, Bongartz, Georg
Publicado em 2010

Effects of antithyroid drugs on radioiodine treatment: systematic review and meta-analysis of randomised controlled trials

Por Walter, Martin A, Briel, Matthias, Christ-Crain, Mirjam, Bonnema, Steen J, Connell, John, Cooper, David S, Bucher, Heiner C, Müller-Brand, Jan, Müller, Beat
Publicado em 2007

Somatostatin-based radiotherapy with [(90)Y-DOTA]-TOC in neuroendocrine tumors: long-term outcome of a phase I dose escalation study

Por Marincek, Nicolas, Jörg, Ann-Catherine, Brunner, Philippe, Schindler, Christian, Koller, Michael T, Rochlitz, Christoph, Müller-Brand, Jan, Maecke, Helmut R, Briel, Matthias, Walter, Martin A
Publicado em 2013

Survival after somatostatin based radiopeptide therapy with (90)Y-DOTATOC vs. (90)Y-DOTATOC plus (177)Lu-DOTATOC in metastasized gastrinoma

Por Dumont, Rebecca A, Seiler, Daniela, Marincek, Nicolas, Brunner, Philippe, Radojewski, Piotr, Rochlitz, Christoph, Müller-Brand, Jan, Maecke, Helmut R, Briel, Matthias, Walter, Martin A
Publicado no Am J Nucl Med Mol Imaging (2014)

Peptide Receptor Radionuclide Therapy (PRRT) Outcomes in a North American Cohort With Metastatic Well-Differentiated Neuroendocrine Tumors

Por Sharma, Nancy, Naraev, Boris G., Engelman, Eric S., Zimmerman, M. Bridget, Bushnell, David L., O’Dorisio, Thomas M., O’Dorisio, M. Sue, Menda, Yusuf, Müller-Brand, Jan, Howe, James R., Halfdanarson, Thorvardur R.
Publicado no Pancreas (2017)